Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.61 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.57 |
| ▸ | CASP2 | P42575 | 1/20 | 0.56 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.50 |
| ▸ | SELP | P16109 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9577064 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL28346905 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL18784649 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL18784660 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL17710344 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL11673516 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL10631525 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL1024338 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL18784656 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL27655035 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170198232-A1 | LUBRICATION OIL ADDITIVE AND METHOD FOR MANUFACTURING SAME, AND LUBRICATION OIL COMPOSITION USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2017-07-13 | — | — | US | disclosed |
| EP-3162876-A1 | LUBRICATION OIL ADDITIVE AND METHOD FOR MANUFACTURING SAME, AND LUBRICATION OIL COMPOSITION USING SAME | Idemitsu Kosan Co., Ltd (JP) | 2017-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170198232-A1 | LUBRICATION OIL ADDITIVE AND METHOD FOR MANUFACTURING SAME, AND LUBRICATION OIL COMPOSITION USING SAME | NAP1L1, SYVN1, NR0B1 | FAAH 1453/4885SLC6A5 3082/4885DNM1 786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.